[go: up one dir, main page]

AU2002337831A1 - Methods of diagnosis of autoimmune disease - Google Patents

Methods of diagnosis of autoimmune disease

Info

Publication number
AU2002337831A1
AU2002337831A1 AU2002337831A AU2002337831A AU2002337831A1 AU 2002337831 A1 AU2002337831 A1 AU 2002337831A1 AU 2002337831 A AU2002337831 A AU 2002337831A AU 2002337831 A AU2002337831 A AU 2002337831A AU 2002337831 A1 AU2002337831 A1 AU 2002337831A1
Authority
AU
Australia
Prior art keywords
diagnosis
methods
autoimmune disease
autoimmune
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002337831A
Inventor
Franck Grall
Xuesong Gu
Towia Libermann
Oltea Tautu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beth Israel Deaconess Medical Center Inc
Original Assignee
Beth Israel Deaconess Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Deaconess Medical Center Inc filed Critical Beth Israel Deaconess Medical Center Inc
Publication of AU2002337831A1 publication Critical patent/AU2002337831A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002337831A 2001-10-12 2002-10-15 Methods of diagnosis of autoimmune disease Abandoned AU2002337831A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32915801P 2001-10-12 2001-10-12
US60/329,158 2001-10-12
US37613902P 2002-04-26 2002-04-26
US60/376,139 2002-04-26
PCT/US2002/032116 WO2003034896A2 (en) 2001-10-12 2002-10-15 Methods of diagnosis of autoimmune disease

Publications (1)

Publication Number Publication Date
AU2002337831A1 true AU2002337831A1 (en) 2003-05-06

Family

ID=26986677

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002337831A Abandoned AU2002337831A1 (en) 2001-10-12 2002-10-15 Methods of diagnosis of autoimmune disease

Country Status (2)

Country Link
AU (1) AU2002337831A1 (en)
WO (1) WO2003034896A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004015100A1 (en) 2002-08-08 2004-02-19 Riken Method of judging inflammatory disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3695099A (en) * 1998-04-27 1999-11-16 Hsc Research And Development Limited Partnership Ese genes and proteins
EP1087985A1 (en) * 1998-06-16 2001-04-04 The Regents of the University of California Exons 4 and 7 encode separate transactivating and chromatin localizing domains in esx

Also Published As

Publication number Publication date
WO2003034896A2 (en) 2003-05-01
WO2003034896A3 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
AU2002331850A1 (en) Methods of endobronchial diagnosis using imaging
AU2002357155A1 (en) Endoscopic imaging system
AU2003224414A1 (en) Acoustic diagnosis of sinusitis
AU2002306501A1 (en) Image analysis of the golgi complex
AU2003298911A1 (en) Cyclosporins for the treatment of autoimmune diseases
AU2002308315A1 (en) Diagnosis of physiological conditions by proteomic characterization
EP1424931A4 (en) Early diagnosis of stroke
AU2002327860A1 (en) Diagnostic methods
AU2002210438A1 (en) Diagnosis of diseases which are associated with cd24
AUPR610501A0 (en) Treatment of parasitic disease
AU4962001A (en) Diagnosis of autoimmune disease
AU2003222250A1 (en) Treatment of autoimmune diseases
AU2003277202A1 (en) Methods for diagnosing bone turnover disease
AU2002250041A1 (en) Putative human enzymes
AU2002337831A1 (en) Methods of diagnosis of autoimmune disease
AU2002350975A1 (en) Diagnosis of inflammatory bowel disease
AU2002339114A1 (en) Diagnosis demyelinating or spongiform disease
AU2002309857A1 (en) Vaccines for the treatment of autoimmune disease
AU2001253219A1 (en) Composition for treatment of autoimmune disease
AU2003207273A1 (en) Method of examining allergic disease
AUPR265601A0 (en) Diagnosis methods
AU2003234488A1 (en) Diagnosis of glaucoma
AU2002337330A1 (en) Diagnosis of cervical cancer
AU2002248511A1 (en) Methods of screening for disease
AU2002320673A1 (en) Method of examining allergic disease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase